Skip to content

Xela Rederm

by Yuria-pharm LLC Ukraine EUDAMED

Ref 2SQModel Injectable implant based on hyaluronic acid XELA REDERM 2.2% 1 ml

EMDN P900402

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-000034545XELAREDER2SQZU Basic UDI-DIDate9 Jul 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Injectable implant based on hyaluronic acid XELA REDERM
Model / Reference
Injectable implant based on hyaluronic acid XELA REDERM 2.2% 1 ml, 2SQ
Primary DI / UDI-DI
D-000034545XELAREDER2SQZU
Basic UDI-DI
B-000034545XELAREDER2SQZU
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
Market of Registration
Lithuania

Manufacturer details

EUDAMED SRN
UA-MF-000034545
Authorised representative
Diaco Biofarmaceutici srl IT-AR-000021064

Other devices from Yuria-pharm LLC

See all devices from Yuria-pharm LLC →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
Other properties (9)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED D-000034545XELAREDER2SQZU|B-000034545XELAREDER2SQZU 61 fields · synced 24 Oct 2026